Cargando…

Mesenchymal stem cell therapy in type 2 diabetes mellitus

Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of insulin-producing cells (IPCs) was once thought to be the most promising strategy for treating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Li, Hao, Haojie, Liu, Jiejie, Li, Yijun, Han, Weidong, Mu, Yiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433043/ https://www.ncbi.nlm.nih.gov/pubmed/28515792 http://dx.doi.org/10.1186/s13098-017-0233-1

Ejemplares similares

Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
por: Yin, Yaqi, et al.
Publicado: (2018)

Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats
por: Sun, Xiaoya, et al.
Publicado: (2017)

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity
por: Si, Yiling, et al.
Publicado: (2012)

Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice
por: Gao, Jieqing, et al.
Publicado: (2019)

Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice
por: Li, Bing, et al.
Publicado: (2019)

Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
por: Xue, Jing, et al.
Publicado: (2020)

Mild hyperglycemia triggered islet function recovery in streptozotocin‐induced insulin‐deficient diabetic rats
por: Cheng, Yu, et al.
Publicado: (2016)

Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial
por: Zang, Li, et al.
Publicado: (2022)

Anti-obesity effect and mechanism of mesenchymal stem cells influence on obese mice
por: Xie, Zongyan, et al.
Publicado: (2021)

Hypoxia Pretreatment of Bone Marrow Mesenchymal Stem Cells Facilitates Angiogenesis by Improving the Function of Endothelial Cells in Diabetic Rats with Lower Ischemia
por: Liu, Jiejie, et al.
Publicado: (2015)

Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy
por: Jin, Liyuan, et al.
Publicado: (2019)

Culturing on Wharton's Jelly Extract Delays Mesenchymal Stem Cell Senescence through p53 and p16INK4a/pRb Pathways
por: Hao, Haojie, et al.
Publicado: (2013)

Beta-cell regeneration from vimentin(+)/MafB(+) cells after STZ-induced extreme beta-cell ablation
por: Cheng, Yu, et al.
Publicado: (2015)

Insight into Reepithelialization: How Do Mesenchymal Stem Cells Perform?
por: Chen, Deyun, et al.
Publicado: (2016)

A Conditioned Medium of Umbilical Cord Mesenchymal Stem Cells Overexpressing Wnt7a Promotes Wound Repair and Regeneration of Hair Follicles in Mice
por: Dong, Liang, et al.
Publicado: (2017)

Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2
por: Jin, Liyuan, et al.
Publicado: (2020)

Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis
por: Li, Yanju, et al.
Publicado: (2021)

Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus
por: Lian, Xiao-Fen, et al.
Publicado: (2022)

Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus
por: Dai, Pengxiu, et al.
Publicado: (2022)

Mesenchymal Stem Cell Therapy in Diabetes Mellitus: Progress and Challenges
por: El-Badri, Nagwa, et al.
Publicado: (2013)

Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules
por: Liu, Jianping, et al.
Publicado: (2013)

LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b
por: Ti, Dongdong, et al.
Publicado: (2015)

Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
por: Rekittke, Nadine E., et al.
Publicado: (2016)

Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy
por: Liu, Meng, et al.
Publicado: (2008)

Granulocyte-Colony Stimulating Factor (G-CSF) Accelerates Wound Healing in Hemorrhagic Shock Rats by Enhancing Angiogenesis and Attenuating Apoptosis
por: Huang, Hong, et al.
Publicado: (2017)

Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
por: Huang, Qiulan, et al.
Publicado: (2021)

Efficacy of mesenchymal stem cell therapy on glucose levels in type 2 diabetes mellitus: A systematic review and meta‐analysis
por: Ranjbaran, Hossein, et al.
Publicado: (2020)

A study on the status of normoalbuminuric renal insufficiency among type 2 diabetes mellitus patients: A multicenter study based on a Chinese population
por: Jia, Xiaomeng, et al.
Publicado: (2021)

Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications
por: Sun, Fengtian, et al.
Publicado: (2022)

Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats
por: Yu, Songyan, et al.
Publicado: (2019)

Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus
por: Hashemian, Seyed Jafar, et al.
Publicado: (2015)

Exosome Degeneration in Mesenchymal Stem Cells Derived from Patients with Type 1 Diabetes Mellitus
por: Horiguchi, Michiko, et al.
Publicado: (2021)

Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial
por: Lian, Xiao-Fen, et al.
Publicado: (2023)

Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus
por: Mikłosz, Agnieszka, et al.
Publicado: (2023)

Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes
por: Li, Yijun, et al.
Publicado: (2015)

Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway
por: Li, Balun, et al.
Publicado: (2021)

Current progress in stem cell therapy for type 1 diabetes mellitus
por: Chen, Shuai, et al.
Publicado: (2020)

Stem cell therapy for diabetes mellitus
por: Voltarelli, Júlio C, et al.
Publicado: (2011)

Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes
por: Gao, Shuang, et al.
Publicado: (2022)

Fulminant type 1 diabetes mellitus in pregnancy
por: Li, Chun-Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gqgf618tcevmsi8goigbb2qt7a